Liminatus Pharma, Inc. (LIMN) stock
LIMNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMNW
$2.81−0.16 (-5.39%)
Close on Nov 17, 2026Market cap $188.72MP/E –Yield –
Liminatus Pharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Liminatus Pharma's market cap was $164.56M on Nov 11, 2026, against $1.41B a year earlier.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $164.56M | -80.1% |
| 2025 | Dec 31, 2025 | $825.47M | – |
See a number that looks wrong?